Key Points of Beta Thalassemia

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 183 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Case Studies in Pediatric Hematology. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Case Studies in Pediatric Hematology (online CE course)
Key Points of Beta Thalassemia

There are two beta globin genes and beta thalassemia results when mutations (not deletions) occur in one or both beta globin genes. The more gene mutations, the more severe the anemia. Infants usually present during the first year of life and are asymptomatic at birth.

Beta Thalassemia Minor/TraitBeta Thalassemia Major
Mutation in one of the two beta chain genes
Both genes are deleted and there is limited to no beta globin production
Asymptomatic mild microcytic hypochromic anemia
Presents around one year of age with severe anemia, jaundice, splenomegaly, growth restriction, and bone malformations. This is a hemolytic anemia. Can lead to death if not treated with chronic blood transfusions.

Peripheral smear findings: target cells and basophilic stipplingPeripheral smear findings: NRBCs, microcytic hypochromic anemia, target cells
Increased amount of Hb A2 and normal Hb FHb F is often 95-100%

Other laboratory findings:
Signs of hemolysis:
  • Increased lactate dehydrogenase (LDH) and indirect bilirubin. Both are released as RBCs breakdown.
  • Decreased haptoglobin. Haptoglobin is used up as it binds the released hemoglobin from the lysed RBCs.
  • Negative Coombs test. A positive Coombs test would indicate an immune system related hemolysis. Thalassemia is not an immune phenomenon.
Signs of iron overload:
  • Increased serum iron. Iron is increased due to the ineffective erythropoiesis and as a result of life-long transfusions.